
Abstract LB-325: New synergistic mTOR-based combinations for the treatment of Ewing sarcoma
Author(s) -
Brian A. Menegaz,
Branko Cuglievan,
Prasad Admane,
Feng Yang,
Dimitrov Dimiter,
Yosef Landesman,
SalahEddine Lamhamedi Cherradi,
Joseph A. Ludwig
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-lb-325
Subject(s) - pi3k/akt/mtor pathway , everolimus , cancer research , medicine , sarcoma , insulin like growth factor , metastasis , cancer , pharmacology , receptor , biology , growth factor , signal transduction , microbiology and biotechnology , pathology